Diphtheria, tetanus, acellular pertussis, poliomyelitis and Haemophilus influenzae type b conjugate vaccine (GlaxoSmithKline)

N/A

Report date: 2024/12/11 10:05:04

Base Information

Drug NameDiphtheria, tetanus, acellular pertussis, poliomyelitis and Haemophilus influenzae type b conjugate vaccine (GlaxoSmithKline)

Drug Alias NameInfanrix Hib

ClassificationVaccines > Biological material > Bacterial vaccineVaccines > Development/production technology > Conjugated vaccineVaccines > Application > Prophylactic vaccine +[4]

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsTetanusDiphtheriaHaemophilus Infections +[4]

Global Approved IndicationsTetanusDiphtheriaHaemophilus Infections +[4]

Approved Indications in ChinaN/A

Original Approved Country/TerritoryGermany

Original Approved Date1996/10/01

Country/TerritoryCzechiaGermanySpain

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaN/A

Originator CompaniesGlaxosmithkline Plc

China Registration ClassN/A

Develop Information

Active CompaniesGlaxosmithkline Plc

Inactive CompaniesN/A

Active IndicationsTetanusDiphtheriaHaemophilus Infections +[4]

Inactive IndicationsN/A

Other Information

ATC CodeJ07BB